 This study found that adjuvant chemotherapy may provide greater health benefits to older, multi-morbid patients with non-small cell lung cancer and a CLC compared to observation. This suggests that adjuvant chemotherapy should be considered as a viable option for this population. This article was authored by Amanda Leiter, Chungin Kong, Michael K. Gould, and others.